Your Article Summary
See Latest ArticlesRole of protein phosphatases and mitochondria in the neuroprotective effects of estrogens
Frontiers in Neuroendocrinology, 06/25/09
Simpkins JW et al. - In the present treatise, the authors provide evidence that the neuroprotective and mito-protective effects of estrogens are inexorably linked and involve the ability of estrogens to maintain mitochondrial function during neurotoxic stress. This is achieved by the induction of nuclear and mitochondrial gene expression, the maintenance of protein phosphatases levels in a manner that likely involves modulation of the phosphorylation state of signaling kinases and mitochondrial pro- and anti-apoptotic proteins, and the potent redox/antioxidant activity of estrogens.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies
European Journal of Endocrinology, 11/05/09
PTH and IL21R May Underlie Variation of Femoral Neck Bone Mineral Density as Revealed by a Genome-Wide Association Study
Journal of Bone and Mineral Research, 11/03/09
Bone signaling pathways and treatment of osteoporosis
Expert Review of Endocrinology & Metabolism, 11/10/09
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09
Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09